Greater pharmacodynamic efficacy of ticagrelor compared to clopidogrel in patients with diabetes mellitus and stable coronary artery disease: a randomized investigation

Back

ESC Premium Access

Greater pharmacodynamic efficacy of ticagrelor compared to clopidogrel in patients with diabetes mellitus and stable coronary artery disease: a randomized investigation

Session: Antithrombotic strategies in coronary artery disease

Topic: Thrombosis and coagulation

Speaker: Doctor A. Marcano (Hospitalet De Llobregat, ES)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Ana Marcano

Bellvitge University Hospital, Hospitalet De Llobregat (Spain)

0 follower

9 more presentations in this session

Antithrombotic treatment in patients with stable CAD and AF - 5-year follow-up data from the CLARIFY registry

Speaker: Doctor R. Wakili (Frankfurt, DE)

Application of DAPT score to predict ischaemic and bleeding events in patients who underwent drug-eluting stent implantation: a landmark analysis of large pooled cohort

Speaker: Doctor Y. Yoshikawa (Kyoto, JP)

Growth differentiation factor 15 and bleeding risk with ticagrelor in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54.

Speaker: Doctor M. Bonaca (Aurora, US)

In-hospital switch of P2Y12 drugs in patients presenting with acute coronary syndrome: a meta-analysis of 14 observational and randomized studies including 10961 patients.

Speaker: Doctor M. Bianco (Orbassano, IT)

Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: OLTAT registry

Speaker: Doctor Q. Fischer (Paris, FR)

Access the full session

Antithrombotic strategies in coronary artery disease

Speakers: Doctor A. Marcano, Doctor R. Wakili, Doctor Y. Yoshikawa, Doctor M. Bonaca, Doctor M. Bianco...

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources